Impact of the Use of Remote Monitoring in the Follow-up of the Renal Transplant Patient.
Condition(s) studied
Investigational drug(s) / intervention(s)
Ap'Telecare: an internet application on a computer, tablet or smartphone
traditional schedule: a group of renal transplant outpatients consulting their Transplant Centre following a traditional schedule
Study summary
Transplant Centers are facing new organisational challenges with regards to the growing number of patients they have to follow-up. We have developed and assessed the feasibility of using a novel web application permitting a medically-tailored follow-up of stable renal transplanted outpatients: Ap'TELECARE. This novel approach is likely to facilitate the organization of patients' follow-up at the Transplant Centre level as well as to provide secondary individual benefits in terms of therapeutic education, adherence to treatment and eventually to improve long term outcome.
Eligibility
Primary outcome measure(s)
- Patients experiencing at least one episode of graft dysfunction — 2 years
graft dysfunction defined by a drop of at least 20% of their usual estimated Glomerular Filtration Rate (eGFR) value)
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| Clermont-Ferrand, CHU Site Gabriel-Montpied | Clermont-Ferrand | France | |
| CHU Saint-Etienne | Saint-Etienne | France |
More Centre Hospitalier Universitaire de Saint Etienne trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03750331 on ClinicalTrials.gov ↗ ← All trials in France